🔎 Trials Near Me

Home › Post-Traumatic Stress Disorder › NCT06670079

Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients

Recruiting

Who can join

Ages 18 and older · Women

Full eligibility criteria
Inclusion Criteria:

* Female
* \>18 years old
* Gestational age ≤ 25 weeks
* Meet current DSM-5 posttraumatic stress disorder criteria based on the Clinician Administered PTSD Scale for DSM-5
* Participants receiving psychotropic medications must be maintained on a stable dose for \>14 days prior to enrollment.

Exclusion Criteria:

* Male
* Under 18 years old
* Gestational age \> 25 weeks
* No current diagnosis of PTSD
* Current delusions or hallucinations, unstable bipolar disorder, imminent risk for suicide as assessed by the Mini International Neuropsychiatric Interview
* Enrolled in another ongoing evidence-based treatment for PTSD.

About the study

The goal of this clinical trial is to learn if a treatment for adults with PTSD called prolonged exposure + incentives (PE+) works to treat pregnant patients. The main question it aims to answer is:

Does PE+ decrease PTSD symptoms?

All participants will receive PE+ to see if their PTSD symptoms at the end of the trial are less than at the beginning.

Participants will:

* Receive individual PE+ therapy for 1 hour weekly for 12 weeks. * Receive financial incentives for attending each PE+ session. * Attend assessment visits every 4 weeks for the 12 weeks of the trial. * Allow research staff to collect some information about their labor and delivery from their medical records after their babies are born.

What is being tested

Sponsor: University of Vermont · Participants: 30 · Started: Feb 5, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT06670079

Locations in the U.S.

VermontUniversity of Vermont, Burlington

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.